XML 13 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities:    
Net Loss $ (2,700,880) $ (5,949,007)
Adjustments to reconcile net loss to net cash from operations    
Depreciation and amortization 417,261 386,250
Bond amortization, net 160,724 (533,123)
Non-cash stock based compensation 0 11,552
Bad debt expense 384 15,534
Realized investment gains (148) (528)
Changes in assets and liabilities:    
Net receivables and accrued investment income 1,874,900 (304,116)
Reinsurance recoverable 77,156 (3,801,282)
Deferred policy acquisition costs 558,841 201,467
Other assets 51,589 478,374
Unpaid losses and loss adjustment expenses 163,351 6,010,728
Unearned premium (2,610,489) 97,396
Advance premium and premium deposits 159,445 206,055
Accrued expenses and other liabilities (367,520) (505,559)
Income taxes current/deferred (647,727) (3,108,695)
Net Cash Used by Operating Activities (2,863,113) (6,794,954)
Cash Flows from Investing Activities:    
Purchase of fixed maturity investments (21,034,427) (44,321,953)
Proceeds from maturity of fixed maturity investments 16,121,354 39,354,000
Proceeds from sale or call of fixed maturity investments 1,270,296 1,594,097
Net (increase) decrease in short-term investments 1,647,778 (2,274,664)
Additions to property and equipment (95,947) (221,281)
Net Cash Used by Investing Activities (2,090,946) (5,869,801)
Cash Flows from Financing Activities:    
Repurchase of common stock (216) 0
Net Cash Used by Financing Activities (216) 0
Net decrease in cash, cash equivalents, and restricted cash (4,954,275) (12,664,755)
Cash, cash equivalents and restricted cash beginning of period 9,366,944 22,602,982
Cash, cash equivalents and restricted cash end of period 4,412,669 9,938,227
Cash paid during the period for:    
Interest 0 0
Income taxes $ 8,800 $ 8,800